GlassScriptPhysician profile
Melannie D White
NPI 1235417452
$1,187.62
in general payments reported to CMS, 2019-2025
14 companies · $23.35 in 2025
The $23.35 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.45 · 2020: $80.31 · 2021: $594 · 2022: $255 · 2023: $130 · 2024: $71.39 · 2025: $23.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $353.88 | 2020-2024 | |
| Stryker Corporation | $301.27 | 2019-2021 | |
| Smith+Nephew, INC. | $120.13 | 2021 | |
| Paratek Pharmaceuticals, INC. | $92.24 | 2021-2024 | Nuzyra |
| Vaporox, INC. | $82.57 | 2023 | |
| Hartmann USA, INC. | $43.22 | 2022 | |
| Kerecis Limited | $40.95 | 2021-2022 | |
| Amgen INC. | $29.91 | 2024 | Krystexxa |
| Averitas Pharma INC. | $28.32 | 2023 | Qutenza |
| Abbott Laboratories | $23.35 | 2025 | Eterna |
| Boston Scientific Corporation | $21.64 | 2021 | |
| Nevro Corp. | $19.24 | 2022 | |
| Convatec INC. | $18.94 | 2023 | |
| Merck Sharp & Dohme LLC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melannie White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.